Feb
25

Wall Street trips and falls on cloudy Italian election

NEW YORK (Reuters) - Stocks on Monday suffered their biggest drop since November after a strong showing in Italian elections by groups opposed to the country's economic reforms triggered worry that Europe's debt problems could once again destabilize the global economy. The decline marks the biggest percentage drop for the benchmark Standard & Poor's 500 Index since November7, and...
Read More..

Huge protest vote pushes Italy towards deadlock

ROME (Reuters) - A huge protest vote by Italians enraged by economic hardship and political corruption pushed the country towards deadlock after an election on Monday, with voting projections showing no coalition strong enough to form a government. With more than two thirds of the vote counted, the projections suggested the center left could have a slim lead in the race for the lower...
Read More..
Feb
24

EADS, ThyssenKrupp attacked by Chinese hackers: report

FRANKFURT (Reuters) – Airbus parent EADS and German steelmaker ThyssenKrupp recorded major attacks by Chinese hackers in 2012, German magazine Der Spiegel reported, citing unidentified people within the two companies.That is a trend seen throughout the German economy, where companies are increasingly being attacked by Chinese hackers, the magazine said, citing information from the German government.A...
Read More..

Channing Tatum & Jenna Dewan-Tatum Show Off Baby Bump at Oscars

By Maggie Coughlan 02/24/2013 at 06:45 PM EST Channing Tatum and Jenna Dewan-Tatum Jason Merritt/Getty Who is your bump wearing?Parents-to-be Channing Tatum and Jenna Dewan-Tatum brought a very special guest to Sunday night's 85th Annual Academy Awards – wearing a black lace, backless dress,...
Read More..

FDA approves new targeted breast cancer drug

WASHINGTON (AP) — The Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones.The drug Kadcyla from Roche combines the established drug Herceptin with a powerful chemotherapy drug and a third chemical linking the medicines together. The chemical keeps the cocktail intact until it binds to a cancer cell, delivering a potent...
Read More..

Investors face another Washington deadline

NEW YORK (Reuters) - Investors face another Washington-imposed deadline on government spending cuts next week, but it's not generating the same level of fear as two months ago when the "fiscal cliff" loomed large. Investors in sectors most likely to be affected by the cuts, like defense, seem untroubled that the budget talks could send stocks tumbling. Talks on the U.S. budget...
Read More..

Syrian opposition says captures former nuclear site

AMMAN (Reuters) - Syrian rebels have captured the site of a suspected nuclear reactor near the Euphrates river which Israeli warplanes destroyed six years ago, opposition sources in eastern Syria said on Sunday. Al-Kubar site, around 60 km (35 miles) west of the city of Deir al-Zor, became a focus of international attention when Israel raided it in 2007. The United States said the complex...
Read More..
Feb
23

Sorry, but there’s no defense for the Chromebook Pixel

I had originally decided not to write about how ridiculous Google’s (GOOG) Chromebook Pixel pricing was on Thursday because I figured it was so self-evident that I’d just be repeating what everyone else was already saying. But today I’ve found two contrarian pieces, one from Quartz and one from ZDNet, that make the case that the Chromebook Pixel actually is a brilliant move on Google’s part even if...
Read More..

From Homeless in the Congo to the Oscars Red Carpet: The Story You Must Read Before Tomorrow

Stylewatch Style News Now 02/23/2013 at 05:40 PM ET Courtesy Rachel MwanzaOne of the best stories from this year’s Oscars ceremony isn’t taking place on screen, but rather on the red carpet.Rachel Mwanza, the 16-year-old star of the Best Foreign Language Film nominee War Witch, will be joining her fellow...
Read More..

FDA approves new targeted breast cancer drug

WASHINGTON (AP) — The Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones.The drug Kadcyla from Roche combines the established drug Herceptin with a powerful chemotherapy drug and a third chemical linking the medicines together. The chemical keeps the cocktail intact until it binds to a cancer cell, delivering a potent...
Read More..